Skip to main content
SpringerLink
Log in

Intensive chemotherapy for a relapsed ALL patient who received living-donor lobar lung transplantation

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Roca J, Granena A, Rodriguez-Roisin R, Alvarez P, Agusti-Vidal A, Rozman C . Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax 1982; 37: 77–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Clark JG, Crawford SW, Madtes DK, Sullivan KM . Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989; 111: 368–376.

    Article  CAS  PubMed  Google Scholar 

  3. Okumura H, Ohtake S, Ontachi Y, Ozaki J, Shimadoi S, Waseda Y et al. Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs? Int J Hematol 2007; 86: 369–373.

    Article  PubMed  Google Scholar 

  4. Sakata-Yanagimoto M, Kanda Y, Nakagawa M, Asano-Mori Y, Kandabashi K, Izutsu K et al. Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1043–1047.

    Article  CAS  PubMed  Google Scholar 

  5. Singal PK, Iliskovic N . Doxorubicin-induced cardiomyopathy. N Engl J Med 1998; 339: 900–905.

    Article  CAS  PubMed  Google Scholar 

  6. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–655.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan

    K Ishiyama, H Okumura, H Yamazaki, Y Kondo, Y Waseda, T Kotani, A Takami & S Nakao

  2. Division of Hematology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan

    K Ishiyama

  3. Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan

    H Okumura

Authors
  1. K Ishiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Okumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Yamazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Waseda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Kotani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Takami
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S Nakao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Ishiyama.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishiyama, K., Okumura, H., Yamazaki, H. et al. Intensive chemotherapy for a relapsed ALL patient who received living-donor lobar lung transplantation. Bone Marrow Transplant 47, 135–136 (2012). https://doi.org/10.1038/bmt.2011.5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.5

  • Springer Nature Limited

Search

Navigation